VISTAGEN THERAPEUTICS, INC. Preferred Stock, Shares Authorized
VISTAGEN THERAPEUTICS, INC. (VTGN) had Preferred Stock, Shares Authorized of 10.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-14
- 2026-06-30: Preferred Stock, Shares Authorized 10.00M shares.
- 2026-03-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2025-12-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2025-09-30: Preferred Stock, Shares Authorized 10.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 10.00M shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 10.00M shares 10-Q · filed 2026-08-14 |
| 2025-12-31 | 10.00M shares 10-Q · filed 2026-02-12 |
| 2025-09-30 | 10.00M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 10.00M shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 10.00M shares 10-K · filed 2026-06-15 |
| 2024-12-31 | 10.00M shares 10-Q · filed 2025-02-13 |
| 2024-09-30 | 10.00M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 10.00M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 10.00M shares 10-K · filed 2025-06-17 |
| 2023-09-30 | 10.00M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 10.00M shares 10-Q · filed 2024-02-13 |
| 2023-06-06 | 10.00M shares 10-Q · filed 2024-02-13 |
| 2023-03-31 | 10.00M shares 10-K · filed 2024-06-11 |
| 2022-12-31 | 10.00M shares 10-Q · filed 2023-02-07 |
| 2022-09-30 | 10.00M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 10.00M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 10.00M shares 10-K · filed 2023-06-28 |
| 2021-12-31 | 10.00M shares 10-Q · filed 2022-02-10 |
| 2021-09-30 | 10.00M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 10.00M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 10.00M shares 10-K · filed 2022-06-23 |
| 2020-12-31 | 10.00M shares 10-Q · filed 2021-02-11 |
| 2020-09-30 | 10.00M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 10.00M shares 10-Q · filed 2020-08-13 |
| 2020-03-31 | 10.00M shares 10-K · filed 2021-06-29 |
| 2019-12-31 | 10.00M shares 10-Q · filed 2020-02-13 |
| 2019-09-30 | 10.00M shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 10.00M shares 10-Q · filed 2019-08-13 |
| 2019-03-31 | 10.00M shares 10-K · filed 2020-06-29 |
| 2018-12-31 | 10.00M shares 10-Q · filed 2019-02-12 |
| 2018-09-30 | 10.00M shares 10-Q · filed 2018-10-29 |
| 2018-06-30 | 10.00M shares 10-Q · filed 2018-08-14 |
| 2018-03-31 | 10.00M shares 10-K · filed 2019-06-25 |
| 2017-12-31 | 10.00M shares 10-Q · filed 2018-02-12 |
| 2017-09-30 | 10.00M shares 10-Q · filed 2017-11-09 |
| 2017-06-30 | 10.00M shares 10-Q · filed 2017-08-14 |
| 2017-03-31 | 10.00M shares 10-K · filed 2018-06-26 |
| 2016-12-31 | 10.00M shares 10-Q · filed 2017-02-13 |
| 2016-09-30 | 10.00M shares 10-Q · filed 2016-11-14 |
| 2016-06-30 | 10.00M shares 10-Q · filed 2016-08-12 |
| 2016-03-31 | 10.00M shares 10-K · filed 2017-06-29 |
| 2015-12-31 | 10.00M shares 10-Q · filed 2016-02-16 |
| 2015-09-30 | 10.00M shares 10-Q · filed 2015-11-16 |
| 2015-06-30 | 10.00M shares 10-Q · filed 2015-08-14 |
| 2015-03-31 | 10.00M shares 10-K · filed 2016-06-24 |
| 2014-12-31 | 10.00M shares 10-Q · filed 2015-02-17 |
| 2014-03-31 | 10.00M shares 10-K · filed 2015-06-29 |
| 2012-03-31 | 0.00 shares 10-K · filed 2012-07-02 |
| 2011-03-31 | 20.00M shares 10-K · filed 2012-07-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |